EnteroMed Ltd Research team is currently conducting three new post-marketing clinical studies in the UK.
Both studies are included in the portfolio of NHS NIHR (National Institute for Health Research).
Study GAST 5337 NIHR portfolio Enterosgel® in treatment of acute diarrhoea in adults
Study PRIM 5338 NIHR portfolio Enterosgel® in treatment of acute atopic skin conditions in adults
Study GAST 34032 NIHR portfolio Enterosgel® in treatment of IBS-D in adults
If you would like to register your interests in upcoming IBS studies, please follow the link: